AXGN
Axogen, Inc. · Healthcare
Director Joseph A. Tyndall sold $174K of Axogen, Inc.
Sold$173,940
$49.70Price
3,500Shares
−25%Stake
What AXGN did after the filing
- The stock from Tue, Sep 8 open, $47.19
- −23.4%
- S&P 500, same days
- 0.0%
Measured over 30 trading days, to the Oct 20 close.
Traded Wed, Sep 2. Filed Fri, Sep 4, 4:08 PM ET, after the close. Returns use the Sep 8 open and the Oct 20 close. Not investment advice.